Testing Mevia’s solutions
Case studies
Case study 1:
In a home care setting, Mevia's solutions were used on 21 residents between the ages of 75 and 90. During the 3-month study, medical deviation decreased from 60% to 14% compared to the same period the year before.
Case study 2:
Fifteen subjects over 80 years of age used Mevia's solutions with placebo medication in multi-dose packages for 4 weeks. With the support of the application, the adherence was 87%.
Download study
Adherence deviation
without Mevia’s solution
Adherence deviation
with Mevia’s solution
Accuracy that the pill actually is taken when it has been taken out from the package.
Is the dose really taken?
Our solutions use electronic monitoring to measure when a pill is taken out from the package. When taken out from the package, studies confirm that 97% also consumes the pill.
Reference: M.Burnier (2019) Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug Adherence
Case studies
Case study 1:
In a home care setting, Mevia’s solutions were used on 21 residents with over 40 people from home care personnel involved. The residents were distributed as 48% male and 52% female with ages ranging between 75-90. During the 3-month study, medical deviation decreased from 60 % to 14 % compared to the same period the year before.
Case study 2:
Fifteen subjects over 80 years of age used Mevia’s solutions with placebo medication in multi-dose packages for 4 weeks. This group of elderly had beforehand been trained in using a smart phone or tablet. The communication and reminders were sent to them via the app. With the support of the service the adherence was 87 %.
Download study report
Adherence deviation
without Mevia’s solution
Adherence deviation
with Mevia’s solution
Is the dose really taken?
Our packaging solutions use electronic monitoring to measure when a pill is taken out from the package. Conceptually, this is an indirect measure of adherence and one cannot assure that once a pill is taken out of the package, the pill is taken. However, studies have confronted this and found a 97% accuracy between the time when a pill is taken out from the package and when it is actually being consumed.
Reference: M.Burnier (2019) Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug Adherence
Adherence deviation without Mevia’s solution
Failure to confirm efficacy,
example: HIV therapy
When self-reporting, 90% reported that they adhere to treatment. When pill-counting it turns out 86% of the patients were adhering to treatment, not 90%. When taking plasma samples through blood tests it turned out only 30% were adhering to treatment, a far less percentage than what was reported by the patients themselves and through pill-counting.
References: Marrazzo JM; VOICE Study Team. “Tenofovir-based preexposure prophylaxis for HIV infection among African women”. N Engl J Med. Article. 2015. Nov. 2020.
.png)
Adherence based on self-reports
Adherence based on returned-products counts
Adherence based plasma samples through blood tests
.png)
